Trademark Search  /  MITODAC

MITODAC

● Live · Registered

U.S. federal trademark · Serial No. 97627312 · Reg. No. 40-2203049

Mark
MITODAC
Status
Registered
Serial Number
97627312
Registration No.
40-2203049
Filing Date
October 11, 2022
Registration Date
June 3, 2024
Class(es)
Class 005

Owners

Curome Biosciences Co., Ltd.
03 · Chungcheongbuk-do,, KR
Curome Biosciences Co., Ltd.
03 · Chungcheongbuk-do,, KR
Curome Biosciences Co., Ltd.
03 · Chungcheongbuk-do,, KR

Goods & Services

Pharmaceutical preparations for treating brain dysfunction; pharmaceutical preparations for treating metabolic disorders; vaccines; pharmaceutical preparations for preventing and treating obesity; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; nutraceuticals for use as a dietary supplement; cardiovascular pharmaceuticals; ophthalmic preparations; pharmaceutical preparations for treating cancer; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical drugs for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical compositions for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceuticals for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations acting on the central nervous system; nutraceutical preparations for therapeutic or medical purposes for medical purposes for the treatment of intractable mitochondrial diseases; pharmaceutical preparations for the treatment of degenerative brain disease

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "MITODAC" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.